Loading clinical trials...
Loading clinical trials...
A Single Center, Double-blind, Parallel-group, Two Factor Patient-Experience Management Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Conditions
Interventions
Deoxycholic Acid Injection
Placebo
+5 more
Locations
1
United States
Investigational Site
Tempe, Arizona, United States
Start Date
December 1, 2013
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
July 28, 2015
Lead Sponsor
Kythera Biopharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions